Summaries for patients. Does interferon-alpha prevent recurrence of malignant tumors in patients with hepatitis C - related liver cancer?
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control* / Q000601:surgery / Q000821:virology*; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008113:Liver Neoplasms / Q000517:prevention & control* / Q000601:surgery / Q000821:virology*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011182:Postoperative Care
D000970:Antineoplastic Agents; D016898:Interferon-alpha